Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Central Excise Central Excise + AT Central Excise - 2021 (6) TMI AT This

  • Login
  • Cases Cited
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2021 (6) TMI 1026 - AT - Central Excise


Issues Involved:
1. Classification of products as ayurvedic medicaments under Chapter 30 or as cosmetics under Chapter 33 of the Central Excise Tariff Act, 1985.
2. Demand for differential duty, interest, and penalties under various provisions of the Central Excise Act, 1944 and Central Excise Rules, 2002.
3. Applicability of amendments made to the Tariff Act effective from 28.02.2005.
4. Burden of proof for classification of products.
5. Application of General Rules for the interpretation of the Schedule to the Central Excise Tariff Act, 1985.

Issue-wise Detailed Analysis:

A. Amendments to the Tariff Act Effective from 28.02.2005:
The Adjudicating Authority emphasized that amendments to Chapter Note 2 of Chapter 33 effective from 28.02.2005 changed the classification criteria. Prior to the amendment, products had to be labeled as cosmetics to fall under Chapter 33, but post-amendment, the requirement was only that the product should be suitable for use as cosmetics and put up in retail packaging. The Tribunal noted that even after the amendment, the products must still be proven to be cosmetics or toilet preparations to be classified under Chapter 33.

B. Burden of Proof for Classification:
The Department failed to conclusively establish that the products were cosmetics. The Tribunal held that the burden of proof lies with the Department to show that the products are classifiable under Chapter 33. The products contained ayurvedic ingredients as per ayurvedic texts, and the Department did not provide sufficient evidence to classify them as cosmetics.

C. Classification as Medicament or Cosmetic:
The Tribunal referred to the Supreme Court's distinction between medicaments and cosmetics, noting that medicaments treat medical conditions while cosmetics enhance appearance. The products in question were found to have therapeutic properties and were used to treat medical issues, thus classifiable as medicaments under Chapter 30. The Tribunal also applied the "twin tests" for classification: common parlance and the presence of ingredients in authoritative ayurvedic texts. The products were perceived as medicaments by users and contained ingredients listed in ayurvedic texts.

D. Application of General Rules for Interpretation:
The Tribunal held that Clause 3(c) of the General Rules for Interpretation, which applies when goods are classifiable under two or more headings, was not applicable. The products were clearly classifiable under Chapter 30 based on their essential character as medicaments.

Conclusion:
The Tribunal concluded that the products manufactured and cleared by the appellant are ayurvedic medicaments under Chapter 30 and not cosmetics under Chapter 33. The appeals filed by the appellant were allowed, and the impugned orders were set aside. The Department's appeal was dismissed. The Tribunal emphasized that the classification must be based on the General Rules, Chapter Notes, and the nature and use of the products.

 

 

 

 

Quick Updates:Latest Updates